Condition
Postprandial Incretins
Total Trials
2
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
7 treatments under study, led by Whey Isolate
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT00809874Not ApplicableCompleted
Effects of Dietary Proteins on Postprandial Lipaemia and Incretin Responses in Obese Subjects
NCT00863564Not ApplicableCompleted
Acute Effects of Dietary Proteins on Postprandial Lipemia, Incretin Responses and Subclinical Inflammation in Obese Subjects
Showing all 2 trials
Research Network
Common Treatments
- Whey Isolate2
- Whey Hydrolysate1
- Caseine1
- Alphalactalbumin1
- Gluten1
Active Sponsors
- Nordic Centre of Excellence2
- Aarhus University Hospital2
- The Danish Obesity Research Centre2
- Arla Foods1
Top Investigators
Department of Endocrinology and Metabolism, Aarhus University Hospital
Related Conditions
- Inflammation1
- Postprandial Inflammation1
- Atherosclerosis1
- Obesity1
- Postprandial Lipemia1